期刊文献+

耐药突变选择窗与抗菌药物防耐药突变浓度的研究进展 被引量:3

Research of Mutant Prevention Concentration and Mutant Selection Window
在线阅读 下载PDF
导出
摘要 突变选择窗(MSW),是指抗菌药物防止细菌选择第一步耐药突变的最低浓度(防耐药突变浓度,MPC)与最小抑菌浓度(MIC)的浓度范围。当血清或组织液药物浓度低于MIC时,治疗无效但也不会导致细菌耐药突变体的富集;超过MPC时细菌要生长需同时具备两种或以上突变,因而不仅治疗成功并且也很难出现耐药突变体的选择性扩增;处于窗内时将选择出耐药突变菌,尽管临床治疗成功率很高,但会促使细菌耐药性的形成。 The mutant selection window(MSW) is an antimicrobial concentration range extending from the the single-step mutant to inhibit the growth of the least susceptible(mutant prevention concentration(MPC))to the minimal concentration(MIC)required to block the growth of wild-type bacteria.When the drug concentration of the blood serum or tissue fluid below the MIC,there will be a Ineffective treatment but it won't lead to bacterial drug-resistant mutants enrichment;When the concentration above the MPC,bacterias need two or more steps' mutant to grow.,so that the treatment will be successful and the drug-resistant mutants will hatd to arise.Placing antimicrobial concentrations inside the window expected to arise the rate of Clinical cures but would enrich resistant mutant subpopulations selectively and lead to more drug resistance.
出处 《四川解剖学杂志》 2012年第2期55-58,共4页 Sichuan Journal of Anatomy
关键词 突变选择窗 防耐药突变浓度 Mutant prevention concentration Mutant selection window
  • 相关文献

参考文献18

  • 1李朝霞,刘又宁.细菌耐药突变选择窗理论与抗菌药物合理应用[J].中国药学杂志,2006,41(16):1201-1205. 被引量:31
  • 2Zhao X. Restricting the selection ofantibiotic-resistant mu- tant: a general strategy drived from fluoroquinolones studies [J]. Clin infect Dis, 2001,33 : S147-156.
  • 3Drlica K. A strategy for fighting antibiotic resistance [ J ]. ASM News,2001,67 :27-33.
  • 4Zhao X, Drlica K. Restricting the selection of antibiotic re- sistants: a general strategy derived from fIuoroquinolones studies[J]. Clin Infect Dis, 2001,33(suppl) :147-156.
  • 5Zhao X, Drlica K. Restricting the selection of antibiotic re- sistant mutant bacteria: measurement and potential use of the mutant selection window[J]. J Infect Dis, 2002, 185, 561- 565.
  • 6Dong Y, Zhao X, Donmagal AJ, et al. Effect of fluoroquin- olone concentration on selection of resistant mutants of myco- bacterium-bovis BCG and staphylococcus aureus[J]. Antimi- crGb Agents Chem-other, 1999, 43(7): 1756-1758.
  • 7Metzler K,Hansen GM,Hedlin P, et ah Comparison of mini- mal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin suscep- tible and resistant. Staphylococcus aureus[J]. Int J Anticicrob Agents, 2004,24 :161-167.
  • 8Zhao X. Clarification of MPC and the mutant selection win- dow concept [J]. Antimicrob Chemother, 2003,52 : 731.
  • 9Zhao X,Drlica K. Restricting the selection of antibiotic-resist- ant mutant baeteriaz Ageneral strategy derived from fluoro- quinoione studies [J]. Clin Infect Dis, 2001,33 (Suppl3) : S147.
  • 10Allen GP, Kaatz W, Rybak MJ. Activities of mutant preven tion concentration- targeted moxifloxacin and levofioxacin a gainst Streptococcus pneumoniae in an in vitro pharmacodyna mic model [J]. Antimicrob Agents Chemother, 2003,47 (8): 2606-2614.

二级参考文献55

共引文献75

同被引文献21

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部